Corina Marx
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- NF-κB Signaling Pathways
-
- Cancer-related Molecular Pathways
Papers in
-
- Histone Deacetylase Inhibitors Research 5
- Ubiquitin and proteasome pathways 4
- Protein Degradation and Inhibitors 4
-
- Cancer, Lipids, and Metabolism 3
- NF-κB Signaling Pathways 1
- Co-authors
- Christopher C. Benz (10 shared papers)Joshua Wong (2 shared papers)Bob B. Buchanan (2 shared papers)Yamei Zhou (3 shared papers)Gary K. Scott (7 shared papers)Jason M. Held (1 shared paper)Bradford W. Gibson (1 shared paper)Mark Shoemaker (3 shared papers)
- Journals
- Cancer Research (4 papers)Journal of Clinical Oncology (2 papers)Clinical Cancer Research (1 paper)Assay and Drug Development Technologies (1 paper)Molecular Pharmacology (1 paper)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Corina Marx
13 papers receiving 792 citations
Peers
Comparison fields: 5 of 72
- Cancer Research 313
- Oncology 197
- Molecular Biology 405
- Biotechnology 41
- Nutrition and Dietetics 57
Countries citing papers authored by Corina Marx
This map shows the geographic impact of Corina Marx's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corina Marx with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corina Marx more than expected).
Fields of papers citing papers by Corina Marx
This network shows the impact of papers produced by Corina Marx. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corina Marx. The network helps show where Corina Marx may publish in the future.
Co-authors
The 25 scholars most cited alongside Corina Marx, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 289 | |
| 2 | 2004 | 113 | |
| 3 | 1999 | 96 | |
| 4 | 2010 | 90 | |
| 5 | 2003 | 86 | |
| 6 | 2008 | 49 | |
| 7 | 2005 | 45 | |
| 8 | 2007 | 22 | |
| 9 | 2004 | 10 | |
| 10 | 2006 | 9 | |
| 11 | 2004 | 5 | |
| 12 | Therapeutic destabilization of ErbB2 transcripts mediated by U-rich mRNA binding proteins and microRNAs. | 2006 | 1 |
| 13 | Proteasome and histone deacetylase inhibitors repress ErbB2 transcript levels and additively inhibit breast cancer growth. | 2004 | 1 |
About Corina Marx
Corina Marx is a scholar working on Molecular Biology, Cancer Research, Surgery, Pharmacology and Oncology, having authored 13 papers that have together received 816 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (5 papers), Ubiquitin and proteasome pathways (4 papers), Protein Degradation and Inhibitors (4 papers), Inflammatory mediators and NSAID effects (3 papers), Cancer, Lipids, and Metabolism (3 papers), Lipoproteins and Cardiovascular Health (3 papers), NF-κB Signaling Pathways (1 paper) and Genetically Modified Organisms Research (1 paper). The work is most often cited by research in Cancer Research (313 citations), Oncology (197 citations), Molecular Biology (405 citations), Biotechnology (41 citations) and Nutrition and Dietetics (57 citations). Corina Marx has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Christopher C. Benz, Joshua Wong, Bob B. Buchanan, Yamei Zhou, Gary K. Scott, Jason M. Held, Bradford W. Gibson, Mark Shoemaker, Christina Yau and Frederick L. Baehner. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Clinical Cancer Research, Assay and Drug Development Technologies and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.